Epidemiological Investigation of Sepsis in Obstetrics Admitted to ICU
1 other identifier
observational
160
1 country
1
Brief Summary
Sepsis is still the main cause of maternal death, accounting for 11% of maternal deaths. Early identification of high risk factors of sepsis and early intervention can improve the prognosis of pregnant women with sepsis. At present, there is no epidemiological investigation report on sepsis in ICU in China.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 3, 2020
CompletedFirst Submitted
Initial submission to the registry
September 14, 2021
CompletedFirst Posted
Study publicly available on registry
September 24, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2022
CompletedSeptember 24, 2021
September 1, 2021
1.1 years
September 14, 2021
September 14, 2021
Conditions
Outcome Measures
Primary Outcomes (3)
The incidence of Maternal sepsis in intensive care unit
The incidence of Maternal sepsis in ICU represents as proportion based on the total number of of maternal ICU admissions and is expressed per 100 deliveries.
January 2008 to December 2019
Sepsis related maternal mortality
Sepsis related maternal mortality in hospitals represents as proportion based on the total number of maternal sepsis in intensive care units and is expressed per 100,000 deliveries.
January 2008 to December 2019
The incidence of multidrug resistance
The incidence of multidrug resistance represents as proportion based on the total number of of maternal sepsis in ICU and is expressed per 100 deliveries. Multidrug resistance was defined as acquired non-susceptibility to at leas one agent in three or more antimicrobial categories.
January 2008 to December 2019
Secondary Outcomes (2)
The length of ICU stay
January 2008 to December 2019
Hospital length
January 2008 to December 2019
Study Arms (2)
Group with sepsis complicated with multidrug-resistant bacteria
Obstetrics diagnosed with sepsis were divided to group with sepsis complicated with multidrug-resistant bacteria if microbial culture results showed multidrug-resistance.
Group with sepsis complicated with none multidrug-resistant bacteria
Obstetrics diagnosed with sepsis were divided to group with sepsis complicated with none multidrug-resistant bacteria if microbial culture results showed none-multidrug-resistance or no positive result of microbial culture.
Interventions
Multidrug resistance was defined as acquired non-susceptibility to at leas one agent in three or more antimicrobial categories.
Eligibility Criteria
Obstetrics with sepsis in any trimester of pregnancy or within 42 days of delivery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Peking University Third Hospitallead
- Beijing Chao Yang Hospitalcollaborator
- Beijing Friendship Hospitalcollaborator
Study Sites (1)
Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Deputy chief doctors
Study Record Dates
First Submitted
September 14, 2021
First Posted
September 24, 2021
Study Start
December 3, 2020
Primary Completion
December 31, 2021
Study Completion
May 31, 2022
Last Updated
September 24, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share